BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 18784270)

  • 1. Cannabinoid modulation of cutaneous Adelta nociceptors during inflammation.
    Potenzieri C; Brink TS; Pacharinsak C; Simone DA
    J Neurophysiol; 2008 Nov; 100(5):2794-806. PubMed ID: 18784270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
    Gutierrez T; Farthing JN; Zvonok AM; Makriyannis A; Hohmann AG
    Br J Pharmacol; 2007 Jan; 150(2):153-63. PubMed ID: 17160008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
    da Fonseca Pacheco D; Klein A; de Castro Perez A; da Fonseca Pacheco CM; de Francischi JN; Duarte ID
    Br J Pharmacol; 2008 Jul; 154(5):1143-9. PubMed ID: 18469844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peripheral cannabinoid receptors attenuates cutaneous hyperalgesia produced by a heat injury.
    Johanek LM; Simone DA
    Pain; 2004 Jun; 109(3):432-442. PubMed ID: 15157704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
    Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
    Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective activation of cannabinoid CB(2) receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation.
    Nackley AG; Makriyannis A; Hohmann AG
    Neuroscience; 2003; 119(3):747-57. PubMed ID: 12809695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endogenous cannabinoids induce fever through the activation of CB1 receptors.
    Fraga D; Zanoni CI; Rae GA; Parada CA; Souza GE
    Br J Pharmacol; 2009 Aug; 157(8):1494-501. PubMed ID: 19681872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinomimetic arachidonyl-2-chloroethylamide (ACEA) acts on capsaicin-sensitive TRPV1 receptors but not cannabinoid receptors in rat joints.
    Baker CL; McDougall JJ
    Br J Pharmacol; 2004 Aug; 142(8):1361-7. PubMed ID: 15277316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cannabinoid CB1 receptor activation inhibits spinal nociceptive transmission in vivo.
    Kelly S; Chapman V
    J Neurophysiol; 2001 Dec; 86(6):3061-4. PubMed ID: 11731561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabinoid CB2 receptor activation inhibits mechanically evoked responses of wide dynamic range dorsal horn neurons in naïve rats and in rat models of inflammatory and neuropathic pain.
    Elmes SJ; Jhaveri MD; Smart D; Kendall DA; Chapman V
    Eur J Neurosci; 2004 Nov; 20(9):2311-20. PubMed ID: 15525273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice.
    Curto-Reyes V; Boto T; Hidalgo A; Menéndez L; Baamonde A
    Eur J Pharmacol; 2011 Oct; 668(1-2):184-9. PubMed ID: 21771590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.
    Rahn EJ; Zvonok AM; Thakur GA; Khanolkar AD; Makriyannis A; Hohmann AG
    J Pharmacol Exp Ther; 2008 Nov; 327(2):584-91. PubMed ID: 18664590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid CB1 receptor inhibition of mechanically evoked responses of spinal neurones in control rats, but not in rats with hindpaw inflammation.
    Kelly S; Chapman V
    Eur J Pharmacol; 2003 Aug; 474(2-3):209-16. PubMed ID: 12921864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of CB1 cannabinoid receptor by inflammation in primary afferent neurons facilitates antihyperalgesic effect of peripheral CB1 agonist.
    Amaya F; Shimosato G; Kawasaki Y; Hashimoto S; Tanaka Y; Ji RR; Tanaka M
    Pain; 2006 Sep; 124(1-2):175-83. PubMed ID: 16709443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous anandamide and cannabinoid receptor-2 contribute to electroacupuncture analgesia in rats.
    Chen L; Zhang J; Li F; Qiu Y; Wang L; Li YH; Shi J; Pan HL; Li M
    J Pain; 2009 Jul; 10(7):732-9. PubMed ID: 19409856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CP55,940 on mechanosensory spinal neurons following chronic inflammation.
    Choong KC; Su X; Urban MO
    Neurosci Lett; 2007 Mar; 414(2):105-9. PubMed ID: 17194542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of the CB(1) receptor antagonists rimonabant and AM251 on the firing rate of dorsal raphe nucleus neurons in rat brain slices.
    Mendiguren A; Pineda J
    Br J Pharmacol; 2009 Nov; 158(6):1579-87. PubMed ID: 19845674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of cannabinoid CB2 receptors suppresses C-fiber responses and windup in spinal wide dynamic range neurons in the absence and presence of inflammation.
    Nackley AG; Zvonok AM; Makriyannis A; Hohmann AG
    J Neurophysiol; 2004 Dec; 92(6):3562-74. PubMed ID: 15317842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitization of C-fiber nociceptors in mice with sickle cell disease is decreased by local inhibition of anandamide hydrolysis.
    Uhelski ML; Gupta K; Simone DA
    Pain; 2017 Sep; 158(9):1711-1722. PubMed ID: 28570479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
    McCollum L; Howlett AC; Mukhopadhyay S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.